SCHEMBL8427465

SCHEMBL8427465

[CH2]CCCCSc1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
KMT2A Q03164 4/20 0.49
MAPT P10636 3/20 0.49
EHMT2 Q96KQ7 1/20 0.47
EHMT1 Q9H9B1 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
RAB9A P51151 5/20 0.45
NPC1 O15118 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 2/20 0.41
PKM P14618 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.41
GRM2 Q14416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5594776 0.98 ALDH1A1 (0.51) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL7812414 0.94 ALDH1A1 (0.54) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL2077935 0.86 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL8621148 0.83 ALDH1A1 (0.54) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL9081971 0.81 HRH1 (0.53) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL7045517 0.81 ALDH1A1 (0.53) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL1743693 0.81 ALDH1A1 (0.53) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL4687623 0.81 ALDH1A1 (0.57) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL4687627 0.81 ALDH1A1 (0.57) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL10974209 0.81 ALDH1A1 (0.56) ALDH1A1KMT2AMAPTEHMT2EHMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942641-A TREATMENT OF ALZHEIMER'S DISEASE, NERVOUS SYSTEM DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-24 US disclosed
EP-0655992-B1 FLUORENONE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND CENTRAL OR PERIPHERAL NERVE DEGENERATION REPAIR AND PROTECTIVE AGENT OTSUKA PHARMA CO LTD (JP) 1998-11-04 EP disclosed
EP-0791570-A1 Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-08-27 EP disclosed
EP-0450066-B1 CARBOSTYRIL DERIVATIVES OTSUKA PHARMA CO LTD (JP) 1996-09-11 EP disclosed
EP-0655992-A1 FLUORENONE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND CENTRAL OR PERIPHERAL NERVE DEGENERATION REPAIR AND PROTECTIVE AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-07 EP disclosed
US-5401740-A FOR INHIBITING PLATELET AGGREGATION OTSUKA PHARMACEUTICAL CO. (JP) 1995-03-28 US disclosed
WO-1995000468-A1 FLUORENONE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND CENTRAL OR PERIPHERAL NERVE DEGENERATION REPAIR AND PROTECTIVE AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-01-05 WO disclosed
US-5227381-A Anticoagulant OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-07-13 US disclosed
EP-0450066-A1 CARBOSTYRIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-10-09 EP disclosed